Proteome Sciences plc
PRM.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£3 | -£2 | £1 | £0 |
| Dep. & Amort. | £1 | £0 | £0 | £0 |
| Deferred Tax | £0 | £0 | -£513 | -£477 |
| Stock-Based Comp. | £0 | £0 | £0 | £1 |
| Change in WC | £1 | £0 | -£0 | -£0 |
| Other Non-Cash | £1 | £1 | £513 | £477 |
| Operating Cash Flow | -£1 | -£0 | £3,882 | £10,522 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£0 | -£0 | -£1,746 | -£1,720 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £0 | -£0 | -£19,927 | £5,990 |
| Investing Cash Flow | -£0 | -£0 | -£21,673 | £4,270 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £1 | -£1 | -£0 | -£0 |
| Stock Issued | £0 | £13,740 | £13,147 | £9,956 |
| Stock Repurch. | £0 | -£5,249 | -£4,133 | -£1,674 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£1 | -£0 | £0 | £0 |
| Financing Cash Flow | £0 | -£1 | -£0 | -£0 |
| Forex Effect | £0 | £0 | £10,330 | -£4,232 |
| Net Chg. in Cash | -£1 | -£2 | £19,584 | £49,064 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £2 | £4 | £259,206 | £210,142 |
| End Cash | £1 | £2 | £278,790 | £259,206 |
| Free Cash Flow | -£1 | -£1 | £2,136 | £8,802 |